rabeprazole has been researched along with Abdominal Injuries in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Abdominal Injuries: General or unspecified injuries involving organs in the abdominal cavity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For the rate of adverse events, there was no significant difference among all the PPIs, vonoprazan, and placebo." | 2.82 | Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis. ( Chen, J; Deng, W; Xie, Z; Yang, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, S | 3 |
| Deng, W | 3 |
| Xie, Z | 3 |
| Chen, J | 3 |
1 review available for rabeprazole and Abdominal Injuries